H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice

The risk of secondary infection with SARS-CoV-2 and influenza A virus is becoming a practical problem that must be addressed as the flu season merges with the COVID-19 pandemic. As SARS-CoV-2 and influenza A virus have been found in patients, understanding the in vivo characteristics of the secondar...

Full description

Bibliographic Details
Main Authors: Heng Li, Xin Zhao, Yurong Zhao, Jing Li, Huiwen Zheng, Mengyi Xue, Lei Guo, Jian Zhou, Jinling Yang, Yuanyuan Zuo, Yanli Chen, Zening Yang, Qiqi Fan, Li Qin, Haijing Shi, Longding Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2021.1938241
_version_ 1818498926559363072
author Heng Li
Xin Zhao
Yurong Zhao
Jing Li
Huiwen Zheng
Mengyi Xue
Lei Guo
Jian Zhou
Jinling Yang
Yuanyuan Zuo
Yanli Chen
Zening Yang
Qiqi Fan
Li Qin
Haijing Shi
Longding Liu
author_facet Heng Li
Xin Zhao
Yurong Zhao
Jing Li
Huiwen Zheng
Mengyi Xue
Lei Guo
Jian Zhou
Jinling Yang
Yuanyuan Zuo
Yanli Chen
Zening Yang
Qiqi Fan
Li Qin
Haijing Shi
Longding Liu
author_sort Heng Li
collection DOAJ
description The risk of secondary infection with SARS-CoV-2 and influenza A virus is becoming a practical problem that must be addressed as the flu season merges with the COVID-19 pandemic. As SARS-CoV-2 and influenza A virus have been found in patients, understanding the in vivo characteristics of the secondary infection between these two viruses is a high priority. Here, hACE2 transgenic mice were challenged with the H1N1 virus at a nonlethal dose during the convalescent stage on 7 and 14 days post SARS-CoV-2 infection, and importantly, subsequent H1N1 infection showed enhanced viral shedding and virus tissue distribution. Histopathological observation revealed an extensive pathological change in the lungs related to H1N1 infection in mice recovered from SARS-CoV-2 infection, with severe inflammation infiltration and bronchiole disruption. Moreover, upon H1N1 exposure on 7 and 14 dpi of SARS-CoV-2 infection, the lymphocyte population activated at a lower level with T cell suppressed in both PBMC and lung. These findings will be valuable for evaluating antiviral therapeutics and vaccines as well as guiding public health work.
first_indexed 2024-12-10T20:22:12Z
format Article
id doaj.art-7c8112cc888f4d86ab9228fea18bcb7a
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-12-10T20:22:12Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-7c8112cc888f4d86ab9228fea18bcb7a2022-12-22T01:34:59ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512021-01-011011156116810.1080/22221751.2021.1938241H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic miceHeng Li0Xin Zhao1Yurong Zhao2Jing Li3Huiwen Zheng4Mengyi Xue5Lei Guo6Jian Zhou7Jinling Yang8Yuanyuan Zuo9Yanli Chen10Zening Yang11Qiqi Fan12Li Qin13Haijing Shi14Longding Liu15Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People’s Republic of ChinaThe risk of secondary infection with SARS-CoV-2 and influenza A virus is becoming a practical problem that must be addressed as the flu season merges with the COVID-19 pandemic. As SARS-CoV-2 and influenza A virus have been found in patients, understanding the in vivo characteristics of the secondary infection between these two viruses is a high priority. Here, hACE2 transgenic mice were challenged with the H1N1 virus at a nonlethal dose during the convalescent stage on 7 and 14 days post SARS-CoV-2 infection, and importantly, subsequent H1N1 infection showed enhanced viral shedding and virus tissue distribution. Histopathological observation revealed an extensive pathological change in the lungs related to H1N1 infection in mice recovered from SARS-CoV-2 infection, with severe inflammation infiltration and bronchiole disruption. Moreover, upon H1N1 exposure on 7 and 14 dpi of SARS-CoV-2 infection, the lymphocyte population activated at a lower level with T cell suppressed in both PBMC and lung. These findings will be valuable for evaluating antiviral therapeutics and vaccines as well as guiding public health work.https://www.tandfonline.com/doi/10.1080/22221751.2021.1938241SARS-CoV-2H1N1alternate infectionconvalescent stagehACE2 transgenic mice
spellingShingle Heng Li
Xin Zhao
Yurong Zhao
Jing Li
Huiwen Zheng
Mengyi Xue
Lei Guo
Jian Zhou
Jinling Yang
Yuanyuan Zuo
Yanli Chen
Zening Yang
Qiqi Fan
Li Qin
Haijing Shi
Longding Liu
H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
Emerging Microbes and Infections
SARS-CoV-2
H1N1
alternate infection
convalescent stage
hACE2 transgenic mice
title H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
title_full H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
title_fullStr H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
title_full_unstemmed H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
title_short H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
title_sort h1n1 exposure during the convalescent stage of sars cov 2 infection results in enhanced lung pathologic damage in hace2 transgenic mice
topic SARS-CoV-2
H1N1
alternate infection
convalescent stage
hACE2 transgenic mice
url https://www.tandfonline.com/doi/10.1080/22221751.2021.1938241
work_keys_str_mv AT hengli h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT xinzhao h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT yurongzhao h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT jingli h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT huiwenzheng h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT mengyixue h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT leiguo h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT jianzhou h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT jinlingyang h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT yuanyuanzuo h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT yanlichen h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT zeningyang h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT qiqifan h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT liqin h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT haijingshi h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice
AT longdingliu h1n1exposureduringtheconvalescentstageofsarscov2infectionresultsinenhancedlungpathologicdamageinhace2transgenicmice